澳門全民核檢已有結果 累計34個十混一樣本初檢陽性
澳門特區新型冠狀病毒感染應變協調中心表示,是次全民核酸檢測於已於昨日(21日)中午12時結束,採樣了的67.76萬人次已有檢測結果,累計共34個10混1樣本初檢呈陽性,部份仍在覆檢當中,其餘爲陰性。
當局指,根據結果,新型冠狀病毒感染應變協調中心決定,要求全澳居民在今日內進行1次新型冠狀病毒快速抗原檢測,重點區域人羣則必須進行1次快速抗原測試,結果爲陰性後纔可外出進行重點區域核酸檢測。
當局亦昨晚表示,爲應對澳門6月18日至今出現的新型冠狀病毒肺炎疫情,在全民核酸檢測基礎上,針對重點區域及重點人羣,進一步開展一次核酸檢測,以排除可能潛伏於澳門社區的新冠肺炎感染者。重點區域檢測對象包括在高士德大馬路、賈伯樂提督街、鏡湖馬路、罅些喇提督大馬路圍封成的區域居住、工作或活動之人士。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.